Translating Evidence-Based Research into Value-Based Decisions in Oncology

Published Online: Tuesday, November 20, 2012
Follow Pharmacy_Times:
At a meeting hosted by the American Journal of Managed Care, key figures in the managed care industry discussed innovative payment models being utilized by payers and providers.
On Friday, November 16, 2012, the American Journal of Managed Care hosted its first annual live meeting, “Translating Evidence-Based Research into Value-Based Decisions in Oncology.” The meeting, which brought together stakeholders from all sides of the managed care industry, provided an arena for health care professionals to discuss new, innovative payment models being utilized by both payers and providers.
 
To view highlights from the meeting, click here.

Related Articles
Leading groups fighting chronic disease argue that Congress intended for eligible consumers to receive tax credits that help make health coverage bought in either federal or state-run marketplaces more affordable.
The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.
Adults aged 50 years or older who feel comfortable about aging are more likely to seek preventive health care services.
In the pediatric hospital setting, pharmacists most frequently perform drug therapy changes on the cancer ward.
Latest Issues
$auto_registration$